{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T11:44:39Z","timestamp":1795088679089,"version":"4.10.2"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009009","name":"Heilongjiang University of Chinese Medicine","doi-asserted-by":"publisher","award":["No. LH2022H059"],"award-info":[{"award-number":["No. LH2022H059"]}],"id":[{"id":"10.13039\/501100009009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Welfare Application Research Project of the Huzhou Municipal Science and Technology Bureau","award":["No. 2021GZ57"],"award-info":[{"award-number":["No. 2021GZ57"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05336-z","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:09:13Z","timestamp":1763608153000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["ZuoGui Pill Ameliorates Alzheimer\u2019s Disease\u2013Like Pathology in 3xTg-AD Mice by Targeting A\u03b2 Production, Tau Phosphorylation, Synaptic Loss, and Neuroinflammation"],"prefix":"10.1007","volume":"63","author":[{"given":"Song","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"10284","key":"5336_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4","journal-title":"Lancet"},{"issue":"4","key":"5336_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70235","volume":"21","author":"A As","year":"2025","unstructured":"As A (2025) 2025 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 21(4):e70235. https:\/\/doi.org\/10.1002\/alz.70235","journal-title":"Alzheimers Dement"},{"issue":"1","key":"5336_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther 9(1):211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","journal-title":"Signal Transduct Target Ther"},{"key":"5336_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00391-7","author":"T Guo","year":"2020","unstructured":"Guo T, Zhang D, Zeng Y, Huang TY, Xu H, Zhao Y (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-020-00391-7","journal-title":"Mol Neurodegener"},{"issue":"5","key":"5336_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118664","volume":"1867","author":"E Lauretti","year":"2020","unstructured":"Lauretti E, Dincer O, Pratic\u00f2 D (2020) Glycogen synthase kinase-3 signaling in Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) 1867(5):118664. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118664","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"4","key":"5336_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.104","volume":"7","author":"F L\u2019Episcopo","year":"2016","unstructured":"L\u2019Episcopo F, Drouin-Ouellet J, Tirolo C, Pulvirenti A, Giugno R, Testa N, Caniglia S, Serapide MF, et al. (2016) GSK-3\u03b2-induced Tau pathology drives hippocampal neuronal cell death in Huntington\u2019s disease: involvement of astrocyte-neuron interactions. Cell Death Dis 7(4):e2206. https:\/\/doi.org\/10.1038\/cddis.2016.104","journal-title":"Cell Death Dis"},{"key":"5336_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2025.104005","volume":"133","author":"A Rekha","year":"2025","unstructured":"Rekha A, Afzal M, Babu MA, Menon SV, Nathiya D, Supriya S, Mishra SB, Gupta S et al (2025) GSK-3\u03b2 dysregulation in aging: implications for tau pathology and Alzheimer\u2019s disease progression. Mol Cell Neurosci 133:104005. https:\/\/doi.org\/10.1016\/j.mcn.2025.104005","journal-title":"Mol Cell Neurosci"},{"key":"5336_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01189","volume":"11","author":"MS Kwak","year":"2020","unstructured":"Kwak MS, Kim HS, Lee B, Kim YH, Son M, Shin JS (2020) Immunological significance of HMGB1 post-translational modification and redox biology. Front Immunol 11:1189. https:\/\/doi.org\/10.3389\/fimmu.2020.01189","journal-title":"Front Immunol"},{"issue":"1","key":"5336_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01981-4","volume":"17","author":"B Ding","year":"2020","unstructured":"Ding B, Lin C, Liu Q, He Y, Ruganzu JB, Jin H, Peng X, Ji S et al (2020) Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE\/NF-\u03baB signaling pathway in vivo and in vitro. J Neuroinflammation 17(1):302. https:\/\/doi.org\/10.1186\/s12974-020-01981-4","journal-title":"J Neuroinflammation"},{"issue":"5","key":"5336_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1055\/a-2008-7948","volume":"73","author":"S Maheshwari","year":"2023","unstructured":"Maheshwari S (2023) AGEs RAGE pathways: Alzheimer\u2019s disease. Drug Res (Stuttg) 73(5):251\u2013254. https:\/\/doi.org\/10.1055\/a-2008-7948","journal-title":"Drug Res (Stuttg)"},{"key":"5336_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116213","volume":"307","author":"MIG El-Din","year":"2023","unstructured":"El-Din MIG, George MY, Youssef FS (2023) Chemical characterization of the polyphenolic rich fraction of Thunbergia erecta and its therapeutic potential against doxorubicin and cyclophosphamide-induced cognitive impairment in rats. J Ethnopharmacol 307:116213. https:\/\/doi.org\/10.1016\/j.jep.2023.116213","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5336_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01533-w","volume":"22","author":"F Liu","year":"2024","unstructured":"Liu F, Zhao Y, Pei Y, Lian F, Lin H (2024) Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance. Cell Commun Signal 22(1):159. https:\/\/doi.org\/10.1186\/s12964-024-01533-w","journal-title":"Cell Commun Signal"},{"issue":"1","key":"5336_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00596-6","volume":"18","author":"SA M\u00fcller","year":"2023","unstructured":"M\u00fcller SA, Shmueli MD, Feng X, T\u00fcshaus J, Schumacher N, Clark R, Smith BE, Chi A et al (2023) The Alzheimer\u2019s disease-linked protease BACE1 modulates neuronal IL-6 signaling through shedding of the receptor gp130. Mol Neurodegener 18(1):13. https:\/\/doi.org\/10.1186\/s13024-023-00596-6","journal-title":"Mol Neurodegener"},{"issue":"7","key":"5336_CR14","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1002\/ptr.8219","volume":"38","author":"P Chen","year":"2024","unstructured":"Chen P, Guo Z, Lei J, Wang Y (2024) Pomegranate polyphenol punicalin ameliorates lipopolysaccharide-induced memory impairment, behavioral disorders, oxidative stress, and neuroinflammation via inhibition of TLR4-NF-\u043aB pathway. Phytother Res 38(7):3489\u20133508. https:\/\/doi.org\/10.1002\/ptr.8219","journal-title":"Phytother Res"},{"issue":"8","key":"5336_CR15","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.biopsych.2020.02.001","volume":"89","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vassar R, De Strooper B, Hardy J, Willem M, Singh N, Zhou J, Yan R et al (2021) The \u03b2-secretase BACE1 in Alzheimer\u2019s disease. Biol Psychiatry 89(8):745\u2013756. https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.001","journal-title":"Biol Psychiatry"},{"issue":"21","key":"5336_CR16","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1021\/acschemneuro.0c00579","volume":"11","author":"S Das","year":"2020","unstructured":"Das S, Sengupta S, Chakraborty S (2020) Scope of \u03b2-secretase (BACE1)-targeted therapy in Alzheimer\u2019s disease: emphasizing the flavonoid based natural scaffold for BACE1 inhibition. ACS Chem Neurosci 11(21):3510\u20133522. https:\/\/doi.org\/10.1021\/acschemneuro.0c00579","journal-title":"ACS Chem Neurosci"},{"key":"5336_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2023.1139558","volume":"10","author":"Z Li","year":"2023","unstructured":"Li Z, Zhao T, Shi M, Wei Y, Huang X, Shen J, Zhang X, Xie Z et al (2023) Polyphenols: natural food grade biomolecules for treating neurodegenerative diseases from a multi-target perspective. Front Nutr 10:1139558. https:\/\/doi.org\/10.3389\/fnut.2023.1139558","journal-title":"Front Nutr"},{"issue":"3","key":"5336_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","volume":"20","author":"AG Atanasov","year":"2021","unstructured":"Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT (2021) Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov 20(3):200\u2013216. https:\/\/doi.org\/10.1038\/s41573-020-00114-z","journal-title":"Nat Rev Drug Discov"},{"key":"5336_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115323","volume":"294","author":"X Kang","year":"2022","unstructured":"Kang X, Chen L, Yang S, Gong Z, Hu H, Zhang X, Liang C, Xu Y (2022) Zuogui wan slowed senescence of bone marrow mesenchymal stem cells by suppressing Wnt\/\u03b2-catenin signaling. J Ethnopharmacol 294:115323. https:\/\/doi.org\/10.1016\/j.jep.2022.115323","journal-title":"J Ethnopharmacol"},{"key":"5336_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118505","volume":"333","author":"Z Li","year":"2024","unstructured":"Li Z, Liang Y, Wang Y, Lin Y, Zeng L, Zhang Y, Zhu L (2024) Zuogui pills alleviate cyclophosphamide-induced ovarian aging by reducing oxidative stress and restoring the stemness of oogonial stem cells through the Nrf2\/HO-1 signaling pathway. J Ethnopharmacol 333:118505. https:\/\/doi.org\/10.1016\/j.jep.2024.118505","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"5336_CR21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000519010","volume":"29","author":"H Liu","year":"2022","unstructured":"Liu H, Dai Q, Yang J, Zhang Y, Zhang B, Zhong L (2022) Zuogui pill attenuates neuroinflammation and improves cognitive function in cerebral ischemia reperfusion-injured rats. Neuroimmunomodulation 29(2):143\u2013150. https:\/\/doi.org\/10.1159\/000519010","journal-title":"Neuroimmunomodulation"},{"issue":"4","key":"5336_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2174\/0113862073295309240214060857","volume":"28","author":"Y Liu","year":"2025","unstructured":"Liu Y, Wu D, Yan X, Xu X, Zhu J, Li C, Feng Q, Li L et al (2025) Zuogui pill promotes neurite outgrowth by regulating OPN\/ IGF-1R\/PTEN and downstream mTOR signaling pathway. Comb Chem High Throughput Screen 28(4):675\u2013690. https:\/\/doi.org\/10.2174\/0113862073295309240214060857","journal-title":"Comb Chem High Throughput Screen"},{"key":"5336_CR23","doi-asserted-by":"publisher","DOI":"10.2174\/0113862073306093240820113714","author":"Y Huang","year":"2024","unstructured":"Huang Y, Zhong L, Yang J, Dai Q, Zhao L, Zhang M, Liu H (2024) Zuogui pills improve the learning and memory ability of brain-aging mice through the estrogen receptor ER\u03b1 methylation pathway. Comb Chem High Throughput Screen. https:\/\/doi.org\/10.2174\/0113862073306093240820113714","journal-title":"Comb Chem High Throughput Screen"},{"key":"5336_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.119105","volume":"339","author":"Z Li","year":"2025","unstructured":"Li Z, Lin Y, Zou Y, Liang Y, Zeng L, Wang Y, Li Y, Zong Y et al (2025) Zuogui pills ameliorate chemotherapy-induced ovarian aging by improving stemness, regulating cell cycle and reducing apoptosis of oogonial stem cells via the Notch1\/Nrf2 pathway. J Ethnopharmacol 339:119105. https:\/\/doi.org\/10.1016\/j.jep.2024.119105","journal-title":"J Ethnopharmacol"},{"key":"5336_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119455","volume":"344","author":"Y Lin","year":"2025","unstructured":"Lin Y, He Q, Chen B, Li Z, Chen C, Deng W, Li H, Yang J et al (2025) Zuogui pills alleviate iron overload-induced osteoporosis by attenuating ROS-mediated osteoblast apoptosis via the PI3K-AKT pathway and mitigating mitochondrial damage. J Ethnopharmacol 344:119455. https:\/\/doi.org\/10.1016\/j.jep.2025.119455","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5336_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02704-1","volume":"20","author":"QQ Xu","year":"2023","unstructured":"Xu QQ, Su ZR, Yang W, Zhong M, Xian YF, Lin ZX (2023) Patchouli alcohol attenuates the cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease via modulating neuropathology and gut microbiota through suppressing C\/EBP\u03b2\/AEP pathway. J Neuroinflammation 20(1):19. https:\/\/doi.org\/10.1186\/s12974-023-02704-1","journal-title":"J Neuroinflammation"},{"issue":"6","key":"5336_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70480","volume":"31","author":"J Liang","year":"2025","unstructured":"Liang J, Dong X, Yang J, Hu N, Luo X, Cong S, Chen J, Zhao W et al (2025) Buyang huanwu decoction modulates the gut microbiota-C\/EBP\u03b2\/AEP axis to ameliorate cognitive impairment in Alzheimer\u2019s disease mice. CNS Neurosci Ther 31(6):e70480. https:\/\/doi.org\/10.1111\/cns.70480","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"5336_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-03008-0","volume":"21","author":"X Bai","year":"2024","unstructured":"Bai X, Wang B, Cui Y, Tian S, Zhang Y, You L, Chang YZ, Gao G (2024) Hepcidin deficiency impairs hippocampal neurogenesis and mediates brain atrophy and memory decline in mice. J Neuroinflammation 21(1):15. https:\/\/doi.org\/10.1186\/s12974-023-03008-0","journal-title":"J Neuroinflammation"},{"key":"5336_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2023.102346","volume":"133","author":"X Ye","year":"2023","unstructured":"Ye X, Shao S, Wang Y, Su W (2023) Ginsenoside Rg2 alleviates neurovascular damage in 3xTg-AD mice with Alzheimer\u2019s disease through the MAPK-ERK pathway. J Chem Neuroanat 133:102346. https:\/\/doi.org\/10.1016\/j.jchemneu.2023.102346","journal-title":"J Chem Neuroanat"},{"key":"5336_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155942","volume":"133","author":"L Du","year":"2024","unstructured":"Du L, Chen J, Yan J, Xie H, Wang L, Wang R, Han X, Wang Y (2024) Lingguizhugan decoction ameliorates cognitive impairment in AD-like mice by influencing the microbiome-gut-brain axis mediated by SCFAs. Phytomedicine 133:155942. https:\/\/doi.org\/10.1016\/j.phymed.2024.155942","journal-title":"Phytomedicine"},{"key":"5336_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117679","volume":"323","author":"Q Long","year":"2024","unstructured":"Long Q, Li T, Zhu Q, He L, Zhao B (2024) Suanzaoren decoction alleviates neuronal loss, synaptic damage and ferroptosis of AD via activating DJ-1\/Nrf2 signaling pathway. J Ethnopharmacol 323:117679. https:\/\/doi.org\/10.1016\/j.jep.2023.117679","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"5336_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-04774-z","volume":"80","author":"J Chen","year":"2023","unstructured":"Chen J, Fan A, Li S, Xiao Y, Fu Y, Chen JS, Zi D, Zeng LH et al (2023) APP mediates tau uptake and its overexpression leads to the exacerbated tau pathology. Cell Mol Life Sci 80(5):123. https:\/\/doi.org\/10.1007\/s00018-023-04774-z","journal-title":"Cell Mol Life Sci"},{"issue":"s1","key":"5336_CR33","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.3233\/jad-240146","volume":"101","author":"JRM Coimbra","year":"2024","unstructured":"Coimbra JRM, Resende R, Cust\u00f3dio JBA, Salvador JAR, Santos AE (2024) BACE1 inhibitors for Alzheimer\u2019s disease: current challenges and future perspectives. J Alzheimers Dis 101(s1):S53-s78. https:\/\/doi.org\/10.3233\/jad-240146","journal-title":"J Alzheimers Dis"},{"issue":"29","key":"5336_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo3610","volume":"8","author":"N Singh","year":"2022","unstructured":"Singh N, Das B, Zhou J, Hu X, Yan R (2022) Targeted BACE-1 inhibition in microglia enhances amyloid clearance and improved cognitive performance. Sci Adv 8(29):eabo3610. https:\/\/doi.org\/10.1126\/sciadv.abo3610","journal-title":"Sci Adv"},{"issue":"1","key":"5336_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-024-00429-6","volume":"13","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang J, Zhang Z, Ye K (2024) Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies. Transl Neurodegener 13(1):40. https:\/\/doi.org\/10.1186\/s40035-024-00429-6","journal-title":"Transl Neurodegener"},{"issue":"9","key":"5336_CR36","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/s41380-024-02501-z","volume":"29","author":"J Wang","year":"2024","unstructured":"Wang J, Huang Q, Chen X, You Z, He K, Guo Q, Huang Y, Yang Y et al (2024) Tau pathology is associated with synaptic density and longitudinal synaptic loss in Alzheimer\u2019s disease. Mol Psychiatry 29(9):2799\u20132809. https:\/\/doi.org\/10.1038\/s41380-024-02501-z","journal-title":"Mol Psychiatry"},{"issue":"3","key":"5336_CR37","doi-asserted-by":"publisher","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","volume":"172","author":"D Terwel","year":"2008","unstructured":"Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F (2008) Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 172(3):786\u2013798. https:\/\/doi.org\/10.2353\/ajpath.2008.070904","journal-title":"Am J Pathol"},{"issue":"3","key":"5336_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt265","volume":"6","author":"Y Kitagishi","year":"2014","unstructured":"Kitagishi Y, Nakanishi A, Ogura Y, Matsuda S (2014) Dietary regulation of PI3K\/AKT\/GSK-3\u03b2 pathway in Alzheimer\u2019s disease. Alzheimers Res Ther 6(3):35. https:\/\/doi.org\/10.1186\/alzrt265","journal-title":"Alzheimers Res Ther"},{"issue":"5","key":"5336_CR39","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1007\/s12035-023-03217-x","volume":"60","author":"X Peng","year":"2023","unstructured":"Peng X, Guo H, Zhang X, Yang Z, Ruganzu JB, Yang Z, Wu X, Bi W et al (2023) TREM2 inhibits tau hyperphosphorylation and neuronal apoptosis via the PI3K\/Akt\/GSK-3\u03b2 signaling pathway in vivo and in vitro. Mol Neurobiol 60(5):2470\u20132485. https:\/\/doi.org\/10.1007\/s12035-023-03217-x","journal-title":"Mol Neurobiol"},{"key":"5336_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-016-0068-y","volume":"5","author":"B Zhang","year":"2016","unstructured":"Zhang B, Li Q, Chu X, Sun S, Chen S (2016) Salidroside reduces tau hyperphosphorylation via up-regulating GSK-3\u03b2 phosphorylation in a tau transgenic Drosophila model of Alzheimer\u2019s disease. Transl Neurodegener 5:21. https:\/\/doi.org\/10.1186\/s40035-016-0068-y","journal-title":"Transl Neurodegener"},{"issue":"8","key":"5336_CR41","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1080\/1061186x.2024.2365263","volume":"32","author":"M Sai Varshini","year":"2024","unstructured":"Sai Varshini M, Aishwarya Reddy R, Thaggikuppe Krishnamurthy P (2024) Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer\u2019s therapy. J Drug Target 32(8):909\u2013917. https:\/\/doi.org\/10.1080\/1061186x.2024.2365263","journal-title":"J Drug Target"},{"key":"5336_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174772","volume":"918","author":"X Peng","year":"2022","unstructured":"Peng X, Chen L, Wang Z, He Y, Ruganzu JB, Guo H, Zhang X, Ji S et al (2022) Tanshinone IIA regulates glycogen synthase kinase-3\u03b2-related signaling pathway and ameliorates memory impairment in APP\/PS1 transgenic mice. Eur J Pharmacol 918:174772. https:\/\/doi.org\/10.1016\/j.ejphar.2022.174772","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"5336_CR43","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1007\/s12035-024-04449-1","volume":"62","author":"L Qu","year":"2025","unstructured":"Qu L, Xu S, Lan Z, Fang S, Xu Y, Zhu X (2025) Apolipoprotein E in Alzheimer\u2019s disease: focus on synaptic function and therapeutic strategy. Mol Neurobiol 62(3):3040\u20133052. https:\/\/doi.org\/10.1007\/s12035-024-04449-1","journal-title":"Mol Neurobiol"},{"issue":"6","key":"5336_CR44","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00221-024-06841-8","volume":"242","author":"J Zeng","year":"2024","unstructured":"Zeng J, Hu XF, Sun DS, Hong XY, Ma JZ, Feng Q (2024) Alzheimer-like behavior and synaptic dysfunction in 3 \u00d7 Tg-AD mice are reversed with calcineurin inhibition. Exp Brain Res 242(6):1507\u20131515. https:\/\/doi.org\/10.1007\/s00221-024-06841-8","journal-title":"Exp Brain Res"},{"issue":"1","key":"5336_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Target Ther 8(1):359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5336_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8(1):267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"5336_CR47","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41590-024-01772-6","volume":"25","author":"KR Carroll","year":"2024","unstructured":"Carroll KR, Mizrachi M, Simmons S, Toz B, Kowal C, Wingard J, Tehrani N, Zarfeshani A et al (2024) Lupus autoantibodies initiate neuroinflammation sustained by continuous HMGB1:RAGE signaling and reversed by increased LAIR-1 expression. Nat Immunol 25(4):671\u2013681. https:\/\/doi.org\/10.1038\/s41590-024-01772-6","journal-title":"Nat Immunol"},{"key":"5336_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102429","volume":"100","author":"N Vitorakis","year":"2024","unstructured":"Vitorakis N, Piperi C (2024) Pivotal role of AGE-RAGE axis in brain aging with current interventions. Ageing Res Rev 100:102429. https:\/\/doi.org\/10.1016\/j.arr.2024.102429","journal-title":"Ageing Res Rev"},{"issue":"3","key":"5336_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14449","volume":"30","author":"X Zhou","year":"2024","unstructured":"Zhou X, Zhu Y, Gao L, Li Y, Li H, Huang C, Liu Y, Hu A et al (2024) Binding of RAGE and RIPK1 induces cognitive deficits in chronic hyperglycemia-derived neuroinflammation. CNS Neurosci Ther 30(3):e14449. https:\/\/doi.org\/10.1111\/cns.14449","journal-title":"CNS Neurosci Ther"},{"key":"5336_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1155175","volume":"16","author":"R Bhattacharya","year":"2023","unstructured":"Bhattacharya R, Alam MR, Kamal MA, Seo KJ, Singh LR (2023) AGE-RAGE axis culminates into multiple pathogenic processes: a central road to neurodegeneration. Front Mol Neurosci 16:1155175. https:\/\/doi.org\/10.3389\/fnmol.2023.1155175","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"5336_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20(1):165. https:\/\/doi.org\/10.1186\/s12974-023-02853-3","journal-title":"J Neuroinflammation"},{"issue":"1","key":"5336_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02565-0","volume":"19","author":"D Singh","year":"2022","unstructured":"Singh D (2022) Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer\u2019s disease. J Neuroinflammation 19(1):206. https:\/\/doi.org\/10.1186\/s12974-022-02565-0","journal-title":"J Neuroinflammation"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05336-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05336-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05336-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:09:16Z","timestamp":1763608156000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05336-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5336"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05336-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"96"}}